<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03148535</url>
  </required_header>
  <id_info>
    <org_study_id>2016-1-4111</org_study_id>
    <nct_id>NCT03148535</nct_id>
  </id_info>
  <brief_title>Guidance Model of Standardized Treatment of Antidepressants in Bipolar Disorder</brief_title>
  <official_title>Clinical Psychopharmacology Division Institute of Mental Health, Peking University</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The bipolar depression patients of 18-55 years old were recruited. At the time of enrollment,
      the demographic, symptomatic, neuropsychological, neurobiological and genetic data was
      collected. After the completion of the baseline assessment and examination, the patients were
      given lithium carbonate or lithium carbonate combined with SSRI antidepressant treatment.
      Clinical evaluation was performed at 2 and 8 weeks after treatment, including the therapeutic
      efficacy and adverse drug reactions, and monitoring of serum lithium concentration. The
      patients further receive the fMRI scans after treatment for 8 weeks. Through above work, this
      study aimed to provide some guidance for the use of antidepressants in patients with bipolar
      depression.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2017</start_date>
  <completion_date type="Anticipated">December 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>HRSD reduction ratio</measure>
    <time_frame>8 weeks</time_frame>
    <description>HRSD reduction ratio</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>the Use of Antidepressants in Patients With Bipolar Depression</condition>
  <arm_group>
    <arm_group_label>lithium carbonate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>recieve lithium carbonate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>lithium carbonate combined with SSRI antidepressant treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>recieve lithium carbonate combined with SSRI antidepressant treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lithium Carbonate</intervention_name>
    <description>bipolar depression recieve lithium Carbonate treatment</description>
    <arm_group_label>lithium carbonate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lithium carbonate combined with SSRI antidepressant treatment</intervention_name>
    <description>lithium carbonate combined with SSRI antidepressant treatment</description>
    <arm_group_label>lithium carbonate combined with SSRI antidepressant treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 18-55 years old, bipolar depression

        Exclusion Criteria:

          -  other mental illness, serious somatic illnesses, MRI contradictions.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ji-Tao Li, MD</last_name>
    <phone>010-62723742</phone>
    <email>ljt_102124@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Institute of mental health, Peking University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100191</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tianmei Si, PhD.</last_name>
      <phone>8610-82801960</phone>
      <email>si.tian-mei@163.com</email>
    </contact>
    <investigator>
      <last_name>Tianmei Si, PhD.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The first hospital of Hebei Province University</name>
      <address>
        <city>Shijiazhuang</city>
        <state>Hebei</state>
        <zip>050000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xueyi Wang, Professor</last_name>
      <phone>0311-85917290</phone>
    </contact>
    <investigator>
      <last_name>Xueyi Wang</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nanjing Brain Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhijian Yao, PhD.</last_name>
      <phone>86-13851580276</phone>
      <email>zhijianyao@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dalian No.7 People's Hospital</name>
      <address>
        <city>Dalian</city>
        <state>Liaoning</state>
        <zip>116000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shoufu Xie, MD.</last_name>
      <phone>86-18441168381</phone>
      <email>shoufuxie@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 9, 2017</study_first_submitted>
  <study_first_submitted_qc>May 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 11, 2017</study_first_posted>
  <last_update_submitted>May 9, 2017</last_update_submitted>
  <last_update_submitted_qc>May 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking University</investigator_affiliation>
    <investigator_full_name>Si Tianmei</investigator_full_name>
    <investigator_title>Clinical Psychopharmacology Division Institute of Mental Health</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bipolar Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antidepressive Agents</mesh_term>
    <mesh_term>Lithium Carbonate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

